Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

Monday October 12, 2009

DrStockPick.com Stock Report!

**************************************************************

Synopsys, Inc. (Nasdaq: SNPS), a world leader in software and IP for semiconductor design, verification and manufacturing, today introduced its Synphony HLS (High Level Synthesis) solution that integrates M-language and model-based synthesis to deliver up to 10X higher design and verification productivity than traditional RTL flows for communications and multimedia applications. Synphony HLS creates optimized RTL for ASIC and FPGA implementation, architecture exploration and rapid prototyping. In addition, Synphony HLS complements C/C++-based flows by generating C-models for system

...

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Activision Blizzard Inc (ATVI) Aeropostale Inc (ARO) Alexion Pharmaceuticals Inc (ALXN) Basilea Pharmaceutic (BPMUF) BCE Inc (BCE) China Pharma Holdings Inc (CPHI) Comscore Inc (SCOR) DRDGold Ltd (DROOY) EnteroMedics Inc (ETRM) Fidelity National Information Services (FIS) Grand Canyon Education Inc (LOPE) Green Mountain Coffee Roasters Inc (GMCR) Haemonetics Corp (HAE) Hana Biosciences Inc (HNAB) Healthcare Services Group Inc (HCSG) Hecla Mining Co (HL) Merck & Co Inc (MRK) Omnova Solutions Inc (OMN) OSI Systems Inc (OSIS) Radio One Inc (ROIAK) Randgold Resources Ltd (GOLD) Ross Stores Inc (ROST) SupportSoft Inc (SPRT) Tecumseh Products Co (TECUA) Tier Technologies Inc (TIER) Tortoise Capital Resources Corp (TTO) Vertex Pharmaceuticals Inc (VRTX) ...

China Pharma Holdings Inc. (OTCBB: CPHI) develops, manufactures and markets generic and branded specialty pharmaceutical products in China. The company today announced its third-quarter results for the period ended September 30, 2008, marking significant increases in revenues and net income.

China Pharma posted a 52 percent increase in revenues, reported at $12.61 million, up from $8.29 million for the same quarter last year. The company attributes this to its expansion of marketing and promotional activities implemented to boost sales of existing products and the introduction of new ones. Revenue for the nine months ended September 30, 2008 rose 47% year-over-year.

“We are confident that our continued strong revenue growth for the third quarter of 2008 is a reflection of our focus on the largest segments of China’s pharmaceutical market, in disease areas of high incidence and high mortality. Our rapid growth is supported by the ongoing delivery of new products, product

...

Third quarter revenues for China Pharma Holdings, Inc. (OTCBB: CPHI) are projected to be between 40 and 45 percent, the company announced Thursday.

The Chinese company markets and manufactures generic and brand bio-pharmaceutical products. CHPI bases its adjusted forecast on recent healthy sales figures. Helpson Bio-pharmaceutical Co. Ltd. is a wholly-owned subsidiary of CPHI.

“We are very pleased that the sales this quarter have exceeded our prediction,” said Ms. Zhilin Li, China Pharma president and CEO. “This reflects the expansion of our sales force and our continued efforts to increase penetration of our distribution network. “We believe (our) revenue and earnings will maintain continued long-term growth and that this is the best reward for investors.”

Li said the company’s growth is in spite of tough global capital markets and ahead of what she said was a Chinese economy “tending toward a decline.”

Let us hear your thoughts below: